Search | Caixin

di ning

Go

China Begins First Virus Antibody Trials on Healthy People
Gilead Strikes Deal With Indian, Pakistani Firms to Produce Experimental Covid-19 Drug
Eli Lilly Ties Up With Shanghai Junshi to Pursue Covid-19 Therapies

Li Ning, Junshi’s chief executive officer. Lilly will first pay Junshi $10 million, followed by as
Gilead’s Covid-19 Drug Looks Set for U.S. Approval, but Questions Linger
Another Chinese Coronavirus Vaccine Candidate Enters Phase-Two Human Trials
In Depth: WHO Leak Sheds Light on Aborted China Trials of Gilead Coronavirus Drug
China Trials of Gilead’s Experimental Covid-19 Drug Suspended
Two More Covid-19 Vaccine Candidates to Start Human Trials in China
In Depth: Why There Will Be No Quick Cure for Trade After the Pandemic

Tianqiong, He Shujing, Sun Liangzi, Peng Yanfeng and Di Ning contributed to this story.
Virus-Hit Nations Embrace Military-Style Field Hospitals

OR